Investigation of the assortment of medicines for the treatment of chronic obstructive pulmonary disease in the pharmaceutical market of Ukraine

Анотація

The aim of the work – to analyze the assortment of medicines for the treatment of chronic obstructive pulmonary disease (COPD) (bronchodilator therapy (BT). in the modern pharmaceutical market of Ukraine.Materials and Methods. The study of the assortment of drugs was carried out according to the State Register of Medicines of Ukraine, the directory of medicines Compendium online, Anatomical Therapeutic Chemical classification (group of medicines code R03 – remedies for the treatment of obstructive respiratory diseases), online resources for the search of drugs in pharmacies of Ukraine “GeoApteka” and “Tabletki.ua”. The following methods are used: marketing, mathematical and statistical, logical generalization and graphic.Results. Comprehensive marketing evaluation of the domestic pharmaceutical market for medicines used for the treatment of COPD (BT).Conclusions. According to the State Register of Medicines of Ukraine, as of the end of 2019, there are 36 TN medicines for the treatment of COPD (BT) in Ukraine. Analysis of the assortment of drugs showed that foreign pharmaceutical production was dominated by pharmaceutical products in Ukraine (64 %). Among the importing countries of drugs, Germany (31 %), Spain (18 %) and India (13 %) take the first place in the nomenclature of medicines. The leader among domestic manufacturing companies is Multispray LLC, Kharkiv (31 %). The share of mono-preparation for COPD (BT) treatment in the domestic pharmaceutical market is 80 %, two-component drugs – 14 % and combination drugs – 6 %. Since the pharmaceutical market of Ukraine was dominated by overseas medicines used in COPD bronchodilation therapy, the results of the analysis of the assortment confirm the relevance of the development of a new domestic drug that can be used in the treatment of patients with this disease.

Класифікація

Ідентифікатори

Схожі роботи